HighTower Advisors LLC Acquires 5,238 Shares of Cardinal Health, Inc. $CAH

HighTower Advisors LLC increased its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 7.8% during the fourth quarter, HoldingsChannel reports. The firm owned 72,152 shares of the company’s stock after buying an additional 5,238 shares during the period. HighTower Advisors LLC’s holdings in Cardinal Health were worth $14,827,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also bought and sold shares of CAH. Wellington Management Group LLP boosted its holdings in Cardinal Health by 153.2% in the third quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock worth $911,010,000 after purchasing an additional 3,511,579 shares during the last quarter. Holocene Advisors LP boosted its stake in shares of Cardinal Health by 141.4% during the 3rd quarter. Holocene Advisors LP now owns 1,926,170 shares of the company’s stock worth $302,332,000 after acquiring an additional 1,128,358 shares during the last quarter. Barclays PLC raised its holdings in Cardinal Health by 109.3% in the 3rd quarter. Barclays PLC now owns 1,584,214 shares of the company’s stock worth $248,658,000 after purchasing an additional 827,446 shares during the period. SG Americas Securities LLC grew its holdings in Cardinal Health by 3,829.1% during the fourth quarter. SG Americas Securities LLC now owns 727,511 shares of the company’s stock valued at $149,504,000 after purchasing an additional 708,995 shares during the period. Finally, Victory Capital Management Inc. raised its stake in shares of Cardinal Health by 44.9% in the third quarter. Victory Capital Management Inc. now owns 2,284,115 shares of the company’s stock worth $352,165,000 after buying an additional 707,495 shares during the period. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Stock Performance

NYSE CAH opened at $200.42 on Monday. The company has a market cap of $46.94 billion, a P/E ratio of 30.64, a P/E/G ratio of 1.19 and a beta of 0.53. The business’s 50 day moving average price is $205.21 and its 200-day moving average price is $208.82. Cardinal Health, Inc. has a fifty-two week low of $137.75 and a fifty-two week high of $233.60.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, beating analysts’ consensus estimates of $2.79 by $0.38. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The business had revenue of $60.94 billion for the quarter, compared to analysts’ expectations of $62.10 billion. During the same quarter in the previous year, the business posted $2.35 earnings per share. The business’s revenue was up 11.0% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, equities analysts predict that Cardinal Health, Inc. will post 10.76 EPS for the current year.

Cardinal Health Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be given a $0.5158 dividend. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date of this dividend is Wednesday, July 1st. This represents a $2.06 dividend on an annualized basis and a yield of 1.0%. Cardinal Health’s dividend payout ratio is currently 31.19%.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on the company. Robert W. Baird set a $248.00 price objective on Cardinal Health in a research note on Friday, May 1st. Leerink Partners reissued an “outperform” rating and set a $275.00 target price on shares of Cardinal Health in a research note on Monday, March 9th. JPMorgan Chase & Co. lowered their price target on Cardinal Health from $243.00 to $215.00 and set a “neutral” rating on the stock in a report on Monday, May 4th. Weiss Ratings downgraded Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a research note on Tuesday, May 19th. Finally, Barclays lifted their price objective on shares of Cardinal Health from $243.00 to $258.00 and gave the company an “overweight” rating in a research report on Tuesday, February 24th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $241.80.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.